Optimization of lead candidates for an on-demand male contraceptive

按需男性避孕药主要候选药物的优化

基本信息

  • 批准号:
    10803570
  • 负责人:
  • 金额:
    $ 68.93万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-21 至 2028-06-30
  • 项目状态:
    未结题

项目摘要

Mammalian sperm are stored in the epididymis in a dormant state; they are immotile and unable to fertilize the egg. Upon ejaculation, sperm begin swimming and initiate a process called capacitation, where they become competent to fertilize. An initial event in capacitation and activation of motility is the HCO3- induced stimulation of soluble adenylyl cyclase (sAC: ADCY10). Men and male mice with the sAC gene knocked out are infertile, and pharmacological inhibitors specific for sAC block in vitro fertilization and temporarily render male mice infertile. Thus, sAC is a genetic and pharmacologically validated, non-hormonal target essential for male fertility. The overall hypothesis tested in this application is that sAC inhibitors can be designed which can be appropriately dosed to block sperm functions while minimizing undesirable side effects. We propose to test a series of potent, selective sAC inhibitors, using in vitro and in vivo studies of efficacy, safety, and pharmacokinetics, to identify the most well-developed, potent, selective, drug-like, non-toxic sAC inhibitors. The goal of this Project is to advance a compound from this series into preclinical development candidates suitable for development partners to apply for an FDA Investigational New Drug (IND) for a novel oral, non-hormonal contraceptive.
哺乳动物的精子以休眠状态储存在附睾中;他们是不动的,无能的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOCHEN BUCK其他文献

JOCHEN BUCK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOCHEN BUCK', 18)}}的其他基金

Assessing inhibitor efficacy in vivo and developing a biomarker for use during early phase clinical trials
评估抑制剂的体内功效并开发用于早期临床试验的生物标志物
  • 批准号:
    10747157
  • 财政年份:
    2023
  • 资助金额:
    $ 68.93万
  • 项目类别:
On-demand nonhormonal male contraception via ADCY10 inhibition
通过 ADCY10 抑制按需非激素男性避孕
  • 批准号:
    10747153
  • 财政年份:
    2023
  • 资助金额:
    $ 68.93万
  • 项目类别:
Development of new ADCY10 inhibitors
新型 ADCY10 抑制剂的开发
  • 批准号:
    10747158
  • 财政年份:
    2023
  • 资助金额:
    $ 68.93万
  • 项目类别:
On-Demand Pharmacological Contraception by Blocking ADCY 10
通过阻断 ADCY 10 进行按需药物避孕
  • 批准号:
    10017310
  • 财政年份:
    2019
  • 资助金额:
    $ 68.93万
  • 项目类别:
High Throughput screen to identify "first of their kind" activators of ADCY10
高通量筛选,鉴定 ADCY10 的“同类首个”激活剂
  • 批准号:
    10066301
  • 财政年份:
    2019
  • 资助金额:
    $ 68.93万
  • 项目类别:
High Throughput screen to identify "first of their kind" activators of ADCY10
高通量筛选,鉴定 ADCY10 的“同类首个”激活剂
  • 批准号:
    10318579
  • 财政年份:
    2019
  • 资助金额:
    $ 68.93万
  • 项目类别:
Crosstalk between metabolic and signaling pathways involved in sperm capacitation
精子获能涉及的代谢和信号通路之间的串扰
  • 批准号:
    10170392
  • 财政年份:
    2017
  • 资助金额:
    $ 68.93万
  • 项目类别:
Comparative studies on the regulation of metabolism during sperm capacitation
精子获能过程中代谢调节的比较研究
  • 批准号:
    10708929
  • 财政年份:
    2017
  • 资助金额:
    $ 68.93万
  • 项目类别:
Comparative studies on the regulation of metabolism during sperm capacitation
精子获能过程中代谢调节的比较研究
  • 批准号:
    10608684
  • 财政年份:
    2017
  • 资助金额:
    $ 68.93万
  • 项目类别:
Modulating intraocular pressure to treat ocular hypotony and glaucoma
调节眼压治疗眼压低和青光眼
  • 批准号:
    8952180
  • 财政年份:
    2015
  • 资助金额:
    $ 68.93万
  • 项目类别:

相似海外基金

Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 68.93万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 68.93万
  • 项目类别:
    Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 68.93万
  • 项目类别:
    Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 68.93万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 68.93万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 68.93万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 68.93万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 68.93万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 68.93万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
  • 批准号:
    484000
  • 财政年份:
    2023
  • 资助金额:
    $ 68.93万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了